Daniele Santini | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Second-line treatment efficacy and toxicity in older vs. non-older patients with advanced gastric cancer: A multicentre real-world study	JOURNAL OF GERIATRIC ONCOLOGY	2019
L’immunoterapia nel tumore del polmone non a piccole cellule: ritorno al futuro	RECENTI PROGRESSI IN MEDICINA	2019
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study	CANCER BIOLOGY & THERAPY	2018
Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO	ANNALS OF ONCOLOGY	2018
Safety and Efficacy of Cabozantinib in Metastatic Renal-Cell Carcinoma: Real-World Data From an Italian Managed Access Program	CLINICAL GENITOURINARY CANCER	2018
Epidemiologia e caratteristiche delle metastasi ossee	Manuale di oncologia medica	2018
Epidemiologia e caratteristiche delle metastasi ossee	Manuale di oncologia medica	2018
Bone Health in Cancer Patients	Practical Medical Oncology Textbook	2018
Novel Biomarkers predicting the development of bone metastasis in Early Breast Cancer	Dammacco: Oncogenomics	2018
Effects of cabozantinib on bone turnover markers in patients with metastatic renal cell carcinoma	JOURNAL OF CLINICAL ONCOLOGY	2018
Bone Health in Cancer Patients	Practical Medical Oncology Textbook	2018
Novel Biomarkers predicting the development of bone metastasis in Early Breast Cancer	Dammacco: Oncogenomics	2018
The use of SAMe in chemotherapy-induced liver injury	CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY	2018
Lenvatinib in the management of metastatic renal cell carcinoma: a promising combination therapy?	EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY	2018
Multicenter prospective study of angiogenesis polymorphism validation in HCC patients treated with sorafenib. An INNOVATE study protocol	TUMORI	2018
Pharmacogenetics of androgen signaling in prostate cancer: Focus on castration resistance and predictive biomarkers of response to treatment	CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY	2018
Efficacy of anti-EGFR rechallenge in RAS and BRAF wt metastatic colorectal cancer: Clinical and translational results of the phase II CRICKET study by GONO	CANCER RESEARCH	2018
Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors following progression with imatinib, sunitinib and regorafenib	THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY	2018
Development of a new clinical nomogram including velocity rate of disease progression to predict outcome in metastatic colorectal cancer patients treated with bevacizumab beyond progression: A subanalysis from tribe trial	ANNALS OF ONCOLOGY	2018
FAP-related desmoid tumours treated with low dose chemotherapy: results from a multicentre retrospective analysis	JOURNAL OF CLINICAL ONCOLOGY	2018